Company intelligence / Profile preview

Wacker Biotech

Jena, Thuringia, Germanywacker.com ↗

Ownership: Public · WCH
Employees: ~500
Development stage: Commercial

Overview

Wacker Biotech operates globally as a leading microbial CDMO/CMO specializing in the development and GMP manufacture of advanced biologics—including recombinant proteins, vaccines, live biotherapeutic products, plasmid DNA and mRNA. The company enables pharmaceutical partners to bring new therapies from research through clinical trials to commercial launch. It has expanded its capacity significantly with new facilities such as the mRNA competence center in Halle. As a service provider/CDMO rather than an innovator with its own drug pipeline or clinical results portfolio, it does not publish clinical trial outcomes.

Therapeutic areas: Metabolic DisordersRare DiseasesImmunologyPsychiatryInfectious Diseases
Modalities: Therapeutic proteinsVaccinesLive biotherapeutic productsPlasmid DNAmRNA
Industry: Contract Manufacturing Organization

Partnerships

Numerous partnerships with global pharma/biopharma companies via contract development/manufacturing agreements (specific names typically confidential, includes major industry players due to regulatory approvals by FDA/EMA/Japan PMDA/etc.)

Financials

Market cap: $19.8B
Total revenue: $39.3B

Beyond the preview

Go deeper on Wacker Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Wacker Biotech.

Explore the full profile